Australia has secured a COVID vaccine candidate. What happens next? With around 24 million people requiring a dose, questions remain over when and how it will be delivered, who will get first access, and if it will even work at all.
Inquiry told GPs should be ‘essential’ part of pandemic preparedness The RACGP highlighted shortfalls in the Queensland Government’s COVID-19 health response at a parliamentary hearing.
‘Yet to see any robust data’: Russia’s vaccine claims in doubt After less than two months of human trials, Russia has laid claim to the first COVID-19 vaccine. Too good to be true? Experts seem to think so.
Vaccine search: Australian study moves to phase 2 trials As COVID-19 claims more Australian lives and authorities consider longer and harsher lockdown restrictions, newsGP speaks with a leading researcher about the prospect of a vaccine.
Coronavirus endgame: What will it take to bring COVID-19 under firm control? We wiped out smallpox and tamed polio. Now Australia’s experts tell newsGP how we can beat COVID-19.
‘Breakthrough’: More progress in COVID-19 fight Two vaccines and a new treatment show signs of effectiveness against coronavirus, randomised controlled trials find.
Another reason to vaccinate boys and young men against HPV New research has found a causal link between HPV and prostate cancer development.
More evidence suggests no long-term COVID-19 immunity A new longitudinal study has found coronavirus antibodies diminish rapidly within three months of peaking.
Study raises questions over long-term COVID-19 immunity Antibodies in previously infected patients dropped substantially after two to three months.
COVID-19 research receives $66 million boost The funding injection will target four areas of research in the quest for a vaccine and preparation for future pandemics.